Literature DB >> 14649324

Oral immunotherapy with yolk antibodies to prevent infections in humans and animals.

Anders Larsson1, David Carlander.   

Abstract

There is an increasing prevalence of antibiotic-resistant bacteria, which makes traditional antibiotics less effective. It is thus important to find an alternative to the use of antibiotics. Oral administration of specific antibodies is an attractive approach to establish protective immunity against gastrointestinal pathogens in humans and animals. Immunotherapy can also be used against pathogens that are difficult to treat with traditional antibiotics. Laying hens are good producers of specific antibodies. After immunisation, the specific antibodies are transported to the egg yolk from which the antibodies (IgY) can be purified in large quantities. Eggs are also normal dietary components and thus there is practically no risk of toxic side effects of IgY. Yolk antibodies have been shown in several studies to prevent both bacterial and viral infections. We have treated one patient with yolk antibodies against P. aeruginosa daily for more than eight years, which shows that it is possible to use yolk immunotherapy over long treatment periods.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14649324

Source DB:  PubMed          Journal:  Ups J Med Sci        ISSN: 0300-9734            Impact factor:   2.384


  4 in total

1.  Protection of Carassius auratus Gibelio against infection by Aeromonas hydrophila using specific immunoglobulins from hen egg yolk.

Authors:  Xiao-liang Li; Jiang-bing Shuai; Wei-huan Fang
Journal:  J Zhejiang Univ Sci B       Date:  2006-11       Impact factor: 3.066

2.  Prophylactic and therapeutic efficacy of avian antibodies against influenza virus H5N1 and H1N1 in mice.

Authors:  Huan H Nguyen; Terrence M Tumpey; Hae-Jung Park; Young-Ho Byun; Linh D Tran; Van D Nguyen; Paul E Kilgore; Cecil Czerkinsky; Jacqueline M Katz; Baik Lin Seong; Jae Min Song; Young Bong Kim; Hoa T Do; Tung Nguyen; Cam V Nguyen
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

3.  Development of Genotype-Specific Anti-Bovine Rotavirus A Immunoglobulin Yolk Based on a Current Molecular Epidemiological Analysis of Bovine Rotaviruses A Collected in Japan during 2017-2020.

Authors:  Koki Odagiri; Nobuki Yoshizawa; Hisae Sakihara; Koji Umeda; Shofiqur Rahman; Sa Van Nguyen; Tohru Suzuki
Journal:  Viruses       Date:  2020-12-03       Impact factor: 5.048

4.  Anti-HER2 IgY antibody-functionalized single-walled carbon nanotubes for detection and selective destruction of breast cancer cells.

Authors:  Yan Xiao; Xiugong Gao; Oleh Taratula; Stephen Treado; Aaron Urbas; R David Holbrook; Richard E Cavicchi; C Thomas Avedisian; Somenath Mitra; Ronak Savla; Paul D Wagner; Sudhir Srivastava; Huixin He
Journal:  BMC Cancer       Date:  2009-10-02       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.